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ABSTRACT
Sexualized injecting drug use (“SIDU”) is a phenomenon asso-
ciated with a wide array of high-risk injecting and sex-related prac-
tices. This scoping review establishes what is known about MSM 
and SIDU to assess implications for health care and policy.  
Characteristics of MSM for “SIDU” may include being on anti- 
retroviral treatment and urban residency with drivers being chal-
lenging social taboos; a search for intimacy; convenience of 
administration; relationship breakdown and increased restrictions 
in clubs and saunas. Attraction for use appears to be enhance-
ment or prolongation of sexual experiences/pleasure; intimacy 
and the facilitation of a range of potentially “unsafe” sexual 
activity. Traditional services are ill-equipped to address “SIDU” 
because of a lack of knowledge of practices, lack of associated 
vocabulary, and a failure to integrate sexual health with drug 
services. For effective responses, these issues need to be 
addressed.
KEYWORDS 
Sexualized injecting drug 
use; “SIDU”; MSM; service 
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Introduction
We use the term “sexualized injecting drug use (“SIDU”)“ to describe injecting 
drug use (IDU) for the purposes of facilitating, enhancing, or prolonging 
sexual experiences. This phenomenon—which is colloquially known as “slam-
ming” amongst men who have sex with men (MSM)—is associated with high- 
risk injecting and sex-related practices within the broader environment of 
what in the UK is called “Chemsex” and in the USA is called “Party and 
Play”—PnP. ’SIDU’ can be considered a form of IDU which is rarely discussed 
specifically (Edmundson et al., 2018; Maxwell, Shahmanesh, & Gafos, 2019) 
despite significant health needs being identified in this context (Bakker & 
Knoops, 2018). This paper, therefore, is a review of the extant literature on 
the topic to address this gap. The review establishes what is known about 
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MSM’s “SIDU” in order to assess implications for health and drug services in 
terms of future uptake and policy development.
MSM engaging in SIDU are considered a specific high-risk drug-using 
group (European Monitoring Centre for Drugs and Drug Addiction- 
EMCDDA, 2017) and may be considered a subpopulation of sexualized drug 
users (Domínguez, Picazo, Barrenechea-moxo, & González, 2018). “Chemsex” 
or PnP may be defined as “intentional sex under the influence of psychoactive 
drugs, mostly among men who have sex with men” (McCall, Adams, Mason, & 
Willis, 2015, h5790.) and “SIDU” or ‘slamming is the injection of psychoactive 
substances within this context (Bourne, Hickson, Reid, Torres Rueda, & 
Weatherburn, 2014). Drugs that are “slammed” include methamphetamine; 
mephedrone; more rarely ketamine; 3,4 methylene dioxymethamphetamine 
(MDMA) and/or other drugs (Marillier et al., 2017; Stuart & Weymann, 2015). 
These drugs may be referred to as novel psychoactive substances (NPS) which 
can be defined as “substances that have recently become popular/available, 
constituting a reason of current/potential public health concern” (Schifano, 
Orsolini, & Duccio Papanti, 2015, p. 31).
Methods
Scoping reviews are an increasingly common method for exploring broad 
topics (Pham et al., 2014). They allow for the mapping of the available extant 
literature (including “gray” literature) of previously under-researched topics 
(Arksey & O’Malley, 2005). This study used the iterative six-step method 
developed by Levac, Colquhoun, and O’Brien (2010). The six steps are: (1) 
identifying the research question; (2) identifying relevant studies; (3) study 
selection; (4) charting the data; (5) collating, summarizing, and reporting the 
Figure 1. Search Strategy.
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results and (6) an international expert advisory consultation exercise on initial 
findings with a view to establishing the credibility of these in light of the 
literature found and any gaps in the literature that have not been discovered.
The research question for the review was, “What is known about sexual 
injecting drug use (SIDU) in the context of ‘chemsex’ and men who have sex with 
men (MSM)?”
An exploratory search was implemented in April 2019 in the National 
Documentation Center for Drugs and Library catalog in the Republic of 
Ireland. This catalogs all drug pertinent research papers, news, and policy 
documents. This exercise led to a more comprehensive search of Pubmed and 
Google Scholar [Table 1: Search Terms]. The searches on all databases were 
limited to “Humans,” the English language, and publications within 
a timeframe of 2009 to 2019. Identified papers’ references were also examined 
for undiscovered extant literature such as “grey” literature.
Eligibility criteria centered on whether studies considered the practices, health 
implications, and service utilization of MSM engaging in injecting drug use of 
NPS during “chemsex.” Review papers which did not include “new” information 
were excluded. The title and abstract of each citation were screened for relevance 
to these parameters by the lead author; where doubt remained papers were 
further reviewed by coauthors (Levac et al., 2010). Studies that did not include 
the parameters were excluded at this stage.
Mendeley™ software was used to compile all relevant papers and all dupli-
cates were removed. Subsequently, this list was forwarded to an Expert 
Advisory Group of “chemsex” researchers and experts to identify other perti-
nent and previously undiscovered papers for inclusion.
Results
Four hundred and twenty-three papers were retrieved through the database 
search (Figure 1). After duplicates were removed (n = 95), 328 papers were 
screened for intravenous drug use (IDU) leading to the removal of 79 papers. 
Papers which correlated injecting of known chemsex drugs with “SIDU” were 
also excluded, leading to the removal of a further 186 papers. Twelve review 
papers which did not provide any new data were excluded. Two further papers 
Table 1. Search Terms.
Drug Terms Injecting Terms SDU Related Terms
English lan-
guage 
papers 
Retrieved
3-MMC OR 4-MEC OR 4-FA OR cocaine OR 
methamphetamine OR tina OR ketamine 
OR GHB OR GBL OR mephedrone OR meph 
OR methoxetamine OR MDMA OR 
cathinone*
injecting OR slamming 
OR “people who inject 
drugs” OR 
“intravenous drug use”
chemsex OR slamsex 
OR “party n play” OR 
PnP OR “sexualised 
drug use*”
Google 
Scholar: 
403 
Pubmed: 
11
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Table 2. Study type and country.
Author Methodology Country
Ahmed et al. (2016) In-depth interviews United Kingdom
Amaro (2016) Ethnographic research France
Bakker and Knoops (2018) Commentary Netherlands
Bourne et al. (2015) In-depth interviews England
Bourne et al. (2014) In-depth interviews UK
Bjerno (2017) Semi-structured interviews Denmark
Bracchi et al. (2015) Commentary United Kingdom
Chung et al. (2015) Case Report United Kingdom
Dolengevich-Segal et al., (2016) Case report Spain
Deimel et al. (2016) In-depth interviews Germany
Dávila (2016) Ethnographic study Spain
Elliot et al. (2017) Prospective opt out United Kingdom
Frankis et al., 2018 Cross-sectional online survey Scotland
Frankis and Clutterbuck (2017) Commentary United Kingdom
Frederick (2016) Ethnography/critical discourse analysis England
Gilbart and Gobin (2013) Semistructured in-depth quantitative interviews England
Giraudon et al. (2018) Commentary England
Gogarty and Fairman Documentary film United Kingdom
Gonzalez-Baeza et al., 2018 Online survey Spain
Gourlay et al. (2017) In-depth interviews England
Guadamuz and Boonmongkon 
(2018)
Narrative interviews Thailand
Glynn et al. (2018) Survey Ireland
Hopwood, Drysdale, & Treloar 
(2018)
Semi-structured in-depth interviews Australia
Hunt (2012) In-depth interviews United States
Javaid (2018) Critical analysis Ireland
Kirby and Thornber-Dunwell 
(2013)
Correspondence England
Knoops et al. (2015) Mixed Methods Netherlands
Knowles (2019) Commentary Canada
Levy  (2019) Case study South Africa
Marillier et al. (2017) Mixed Methods France
Macleod et al., (2016) Mixed Methods Scotland
Milhet et al. (2019) In-depth interviews France
Moncrieff (2014) Scoping Study England
Molina et al. (2018) Double-blind randomized combined prevention trial France and 
Canada
Mounteney et al. (2016) Mixed Methods Portugal
Mowlabocus et al. (2016) Commentary England
O’Reilly (2018) Case Study Australia
Page and Nelson (2016) Commentary England
Payne et al., (2017) In-depth semistructured interviews Ausralia
Power et al. (2018) Cross-sectional survey Australia
Pufall et al. (2018) Cross-sectional survey England
Ralphs, Gray, and Norton (2017) Mixed Methods England
Stuart (2014a) Tool kit England
Stuart (2014b) Guide England
Stuart & Weymann, 2015 Mixed Methods England
Stuart (2016) Commentary England
Souleymanov (2018) Discourse Analysis Canada
Todd (2016) Book England
Vaux et al. (2019) Cross-sectional survey France
Wendel et al. (2011) Mixed methods: respondent driven sampling, social actor 
theory
United States
Wharton (2017) Book England
Weatherburn et al. (2016) Qualitative semi-structured interviews England
Van Hout et al. (2018) Interpretative Phenomenological Analysis Ireland
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meeting the inclusion criteria were identified through a hand search, yielding 
a total of 53 papers for critical appraisal (See Figure 1).
Specific information including author, year of publication, methodology, 
and study location were noted (See Table 2). Data were broken down thema-
tically into: “SIDU Profile and Catalysts”; “Health Harms”; “Service 
Responses” and “Service Utilisation.”
“SIDU” Profile and Catalysts
SIDU is reported in several countries including the United Kingdom; United 
States; Australia; the Netherlands; France; Spain; Portugal; Thailand; Ireland; 
Czech Republic; Germany; Denmark; Finland and Greece (Glynn et al., 2018; 
Guadamuz & Boonmongkon, 2018; Hopwood, Drysdale, & Treloar, 2018; 
Knoops, Bakker, Van Bodegom, & Zantkuijl, 2015; Wendel, 2011). Reported 
prevalence figures for MSM engaging in “SIDU” range between 1% and 50% 
(Bourne, Reid, Hickson, Torres-Rueda, & Weatherburn, 2015; Elliot, 
Singh, Tyebally, Gedela, & Nelson, 2017; Frankis & Clutterbuck, 2017; 
Frankis, Flowers, McDaid, & Bourne, 2018; Molina et al., 2018; Power et al., 
2018). In a population of HIV-positive MSM recruited through UK health 
clinics, Pufall et al. (2018) found that a minority of MSM reported engaging in 
SIDU: 10.1% (any drug); 4% (multiple drugs); 6.7% (methamphetamine); 0.4% 
(GHB/GBL); ketamine (1.1%) and mephedrone (6.6%). In a small population 
(n = 16) of MSM who used methamphetamine for sex recruited from a variety 
of Australian services (LGBTIQ, viral hepatitis, and harm reduction organiza-
tions) 50% reported engaging in SIDU. The drugs injected may vary according 
to the local context (Giraudon, Jeremias, & Mohammed, 2018) and the drugs 
thought to be injected may vary in purity and can contain close chemical 
analogues—that is compounds having a structure similar to that of another 
compound, but different from it in respect to a certain component in order to 
either bypass drug laws or to input cheaper compounds to maximize profits— 
rather than the substance expected by the user (Marillier et al., 2017).
The term “slamming” may be used by individuals to distinguish recreational 
injecting from traditional social perceptions associated with injecting of 
opioids and other drugs in the broader drug-injecting population (Bourne 
et al., 2014; Gilbart & Gobin, 2013; Knoops et al., 2015). In London, Moncrieff 
(2014) reports that “SIDU” started to occur as MSM moved from licensed gay 
venues and clubs—a move prompted by increased security enforcement 
against recreational drug use—to private parties—a move that was facilitated 
through the use of geospatial mobile applications such as Grindr™; Scruff™; 
Hornet™ and Jack’d™. Ahmed et al. (2016) report that a population of MSM 
from South London boroughs reports SIDU being virtually absent from 
licensed venues due to the stigmatization associated with this behavior and 
the practicality of injecting in a venue with restrictions. Suspected SIDU is 
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reported in a sauna in Barcelona (Dávila, 2016). In South Africa, there have 
been calls for “safe” consumption sites to be established in MSM sex-related 
venues (Levy, 2019).
MSM engaging in “slamsex” operate in different networks within chemsex 
scenes (Knoops et al., 2015). In this regard, “SIDU” is motivated by the excite-
ment associated with crossing a social taboo line (Ralphs, Gray and Norton, 
2017) as this relates to a behavior (injecting) that maybe stigmatized, fetishized 
and carry risks (both social and health)(Van Hout, Crowley, O’Dea, & Clarke, 
2018; Wharton, 2017). In the United Kingdom, the practice is reportedly 
becoming less stigmatized and more normalized within the MSM community 
(Gourlay et al., 2017). “SIDU” may be an opportunity to increase intimacy 
between sexual partners (Hunt, 2012) and a minority within the “SIDU” scene 
may share injecting equipment as the “ultimate form of connectedness” (Knoops 
et al., 2015, p. 31).
Several studies report that “SIDU” facilitates, enhances, and/or prolongs sexual 
experiences (Amaro, 2016; Deimel et al., 2016; Hunt, 2012; Weatherburn, 
Hickson, Reid, Torres-Rueda, & Bourne, 2017). Sexual liberation and self- 
medication for low sex drives can be a motivating factor for “SIDU” (Deimel 
et al., 2016; Milhet, Shah, Madesclaire, & Gaissad, 2019; Souleymanov, 2018; 
Weatherburn et al., 2017). Amaro (2016) reports that many MSM initiate 
“SIDU” after the breakdown of previous relationships. Conversely, “SIDU” 
may facilitate romantic experiences and become a component of forming rela-
tionships with other MSM who “slam” (ibid.). In a Scottish survey of six MSM 
who reported engaging in SIDU, two reported SIDU during 50–100% of all 
sexual encounters (Macleod et al., 2016).
Some male sex workers may engage in “SIDU” to facilitate more extreme 
sexual practices motivated by the opportunity to earn more money from 
clients (Knoops et al., 2015). Weatherburn et al. (2017) report a case where 
“SIDU” allowed an MSM to “get horny” despite no longer having a sex drive. 
Indeed, in that case the respondent reported that “It’s one of the reasons why 
I started using chems” (p. 2).
“SIDU” can lower inhibitions and can increase stamina and performance 
(Dolengevich-Segal, Rodríguez-Salgado, Gómez-Arnau, & Sánchez- 
Mateos,2016). Some ‘SIDU’s inject vasodilators directly into their penises to 
facilitate erections during chemsex sessions (Knoops et al., 2015). The inject-
ing use of crystal methamphetamine has been reported to facilitate movement 
from active to passive sexual roles (Knoops et al., 2015), it is unclear as to what 
extent the injecting behavior itself promotes this sexual role change in com-
parison to other routes of methamphetamine administration.
Moving toward “SIDU” from other forms of administration may serve 
practical purposes as injecting may limit the amount of time required with non- 
injecting administration of a drug (for example, smoking methamphetamine) 
and speeding up the time of the impact of the effect of the drug (Hopwood 
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et al., 2018; Hunt, 2012). It may also decrease side effects from administering 
the drug in other ways—for example, cold-like symptoms from snorting (ibid.).
“SIDU” Practices
Those engaging in “SIDU” may identify themselves on dating apps through 
ideograms such as syringes and suggestive phrases such as “to the poinT” 
(Bourne et al., 2014; Gogarty & Fairman, 2015; Guadamuz & Boonmongkon, 
2018; Knoops et al., 2015). They may also connect with fellow ‘SIDUs’ through 
online forums and porn sites devoted to “SIDU” and may inject communally 
whilst online (Bakker & Knoops, 2018; Frederick, 2016; Guadamuz & 
Boonmongkon, 2018; Mouneteney, Po, Oteo, & Griffiths, 2016; Pirona et al., 
2017; Wendel, 2011).
Whilst low levels of sharing of equipment are reported, MSM who engage in 
SIDU may lack knowledge of proper injecting technique and are reported as 
frequently injected by partners (Bourne et al., 2015). Stuart and Weymann 
(2015) describe a UK-based MSM population engaging in “SIDU” a majority 
of whom surveyed reported not sharing needles; 23% reported never sharing; 
27% reported never injecting themselves; 16% had only injected themselves 
and 30% had injected themselves and others. At times, MSM who engage in 
SIDU may be injected by trained medical professionals (Knoops et al., 2015) 
who are also engaging in SIDU and indeed, are often sought out for their 
medical skill in relation to injecting (Hopwood et al., 2018; Todd, 2016). 
Injecting techniques may be learnt through Youtube™ videos; engagement 
with harm reduction services; watching friends inject; and through training 
from medical professionals (Hopwood et al., 2018).
A tendency not to filter solutions, to mix in the syringe barrel and to 
inadequately dispose of used equipment has also been reported (Knoops 
et al., 2015). Some participants may withdraw their own blood, use it as 
a solvent for injectable drugs, and inject themselves and/or others with this 
solution (Kirby & Thornber-Dunwell, 2013). This interaction can be viewed as 
a power negotiation between sexual participants which renders those with less 
power at a disadvantage (Javaid, 2018).
Dosing may be learnt interactionally between SIDU participants (Bjerno, 
2017). In a case report, Dolengevich-Segal et al. (2016) note that one 
participant (MSM) engaging in SIDU reported injecting 0.1–0.2 mg mephe-
drone every hour, consuming 3–4 grams on a weekend. In some cases, MSM 
engaging in SIDU may stop injecting methamphetamine due to the intensity 
of the experience and may switch to other drugs such as 
4-Methylethcathinone (4-MEC), 3-Methylmethcathinone (3-MMC), 
cocaine, methoxetamine (MXE) or 4-Fluoroamphetamine (4-FA) (Knoops 
et al., 2015).
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“SIDU” appears to be associated with several potentially harmful drug- 
related practices including polydrug use; poor injection technique; injection 
by partners; sharing (sometimes intentionally) of equipment; people not 
filtering solutions; mixing in syringe barrels; using blood as a solvent; frequent 
redosing and prolonged use (Bourne et al., 2014; Knoops et al., 2015). “SIDU” 
has also been associated with several potentially harmful sex-related practices 
to obtain sexual arousal such as fisting (Knoops et al., 2015; Stuart, 2014a; 
Weatherburn et al., 2017).
Health Harms
Injecting and/or polydrug use may expose people who engage in “SIDU” to the 
risk of substance use disorders (Bourne et al., 2014; Knoops et al., 2015). The 
sharing of equipment and using blood as a solvent expose MSM engaging in 
SIDU to increased risk of human immunodeficiency virus (HIV), hepatitis 
C (HCV) and other blood-borne viruses (BBVs) (Bourne et al., 2015; Kirby & 
Thornber-Dunwell, 2013; Knoops et al., 2015; Page & Nelson, 2016; Stuart & 
Weymann, 2015). In an English case study, Chung et al. (2015) report that the 
sharing of a drug-blood mixture led to infection of a second strain of HCV in 
one patient. In a French cross-sectional survey, chronic HCV prevalence of 
10.6% was reported in a population of MSM engaging in SIDU (Vaux et al., 
2019). Further harms that may appear include abscesses; phlebitis; track marks 
and muscle damage (Knoops et al., 2015; Payne et al., 2017). Prolonged use 
may lead to delusional thoughts; paranoid ideation; hallucinations and suicidal 
ideation (Dolengevich-Segal et al., 2016) which can be exasperated by long 
sessions with little sleep and poor nutrition (Bourne et al., 2014).
In a UK study of attendees of HIV clinics, Pufall et al. (2018) found that 
being on anti-retro viral treatment (ART) was a predictor of engaging in 
“chemsex” and that 10.1% of the HIV+ positive MSM engaged in “slamsex.” 
Those engaging in “slamsex” and/or “chemsex” were reportedly likely to have 
more causal partners; serodiscordant unprotected anal intercourse and detect-
able viral load serodiscordant unprotected anal intercourse (Pufall et al., 2018). 
ART medication may exasperate severe organ-related toxicity associated with 
some drugs associated with SIDU (Bracchi et al., 2015).
When compared to a group reporting chemsex but not SIDU, MSM enga-
ging in SIDU were found more likely to report multiple STIs including 
Chlamydia, Gonorrhea, and Syphilis (Pufall et al., 2018). People with HCV 
were found to be more likely to report to engage in SIDU in Madrid, Spain 
(Gonzalez-Baeza et al., 2018) and a minority of an English and Welsh popula-
tion diagnosed with Shigellosis also reported engaging in SIDU (Gilbart & 
Gobin, 2013). HCV infection may occur from both injection and sexual 
practices (Gonzalez-Baeza et al., 2018).
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Service Responses and Engagement
Many people engaging in SIDU may not consider “SIDU” risky and/or may 
see themselves as different when compared with other people who inject drugs 
(Stuart & Weymann, 2015; Frankis & Clutterbuck, 2017; Gogarty & Fairman, 
2015). As a result, it may be more appropriate to have SIDU services within 
existing gay-specific health services (Frankis & Clutterbuck, 2017). One well- 
known service is 56 Dean Street in London in the United Kingdom (Stuart & 
Weymann, 2015).
In a Canadian review Knowles (2019) found that services should seek to 
open discussions within the MSM community; provide culturally competent 
information; talk to MSM about consent and remain sex positive. Canadian 
programs that include such elements include the “Let’s Talk and Test” 
Campaign (cabaret-style evening); “Spill the Tea” Campaign (safer partying 
kits including injecting equipment; lube, condoms, and gloves; snorting kits; 
methamphetamine pipes); AIDS Community of Toronto “Spunk Support” 
Groups (six-week program which includes motivational interviewing; cogni-
tive behavioral therapy and other components); AIDS Community Care 
Montreal’s “Kontak” program (safer partying kits; an available outreach 
worker and the holding of workshops) and Gay Men’s Sexual Health 
Alliance of Ontario (GMSH) “Party and Play Your Way” which is producing 
color-coded injecting packets to reduce the likelihood of sharing equipment 
modeled from the Gay Men’s Health Collective’s “Pic Pacs” (Knowles, 2019).
In a Scottish commentary, Frankis and Clutterbuck (2017) suggest a highly 
personalized approach is required which seeks to minimize biomedical harms. 
Such measures should include:
frequent regular STI testing; for HIV-negative men, HIV testing; and for HIV-negative 
chemsex users who struggle with condom use and safer injecting practices, access to 
postexposure prophylaxis and information on and support with PrEP (whether funded 
or self-sourced). (Frankis & Clutterbuck, 2017, p. 1)
The importance of integrated services and use of chemsex slang during 
interactions has been stressed by several authors (Bakker & Knoops, 2018; 
David; Stuart & Weymann, 2015). A number of specialized services have been 
developed within sexual health services, online, and physical peer outreach 
(Bakker & Knoops, 2018; Hugo et al., 2018; Mowlabocus, Haslop, & Dasgupta, 
2016; Mowlabocus et al., 2016; Stuart & Weymann, 2015).
The United Kingdom-based Chemsex Care Support Plan TM is an online 
motivational interviewing-based intervention which can be used by MSM 
engaging in “SIDU” directly or with a practitioner (O’Reilly, 2018; Stuart & 
Weymann, 2015). This tool is widely utilized in over a dozen languages 
(https://www.davidstuart.org/care-plan) and may be useful in cases where 
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information on “SIDU” is not volunteered and may elicit discussion around 
the topic (O’Reilly, 2018).
As has been discussed previously, several interventions center on commu-
nity engagement such as cabaret-style events, outreach work, and workshops 
(Knowles, 2019). Anova Health Institute utilizes peer support workers to 
engage with MSM engaging in “SIDU” in Cape Town, South Africa (Hugo 
et al., 2018). MSM engaging in SIDU can also be reached through online 
outreach (Mowlabocus et al., 2016).
There is widespread acceptance that non-specialized services for people 
who inject drugs and standard sexual health services are relatively unsuitable 
for people who engage in “SIDU” (Bakker & Knoops, 2018; Bourne et al., 
2014a; Knoops et al., 2015; Stuart & Weymann, 2015). Knoops et al. (2015) 
report that a Dutch population of MSM engaging in “SIDU” “did not know 
local needle exchange programmes even existed, let alone how they worked, 
where they were and when they opened” (p. 59). Those who did know, did not 
use them out of fear of being branded “a junkie” (ibid). Knoops et al. also 
recounts a case where a “SIDU” registered at a local drug-treatment 
clinic and:
found myself having to give an introductory course on crystal meth. She [the drug worker] 
knew nothing about crystal meth. She didn’t know you could inject the drug nor did she 
know its street name. She even asked if tina was my ex-girlfriend’s name. I’d had just about 
enough by then. It had been a complete let down. I went straight back to using. (ibid).
Discussion
“SIDU” is an under-researched and under-reported phenomenon amongst 
MSM populations. “SIDU” by MSM, based upon the above review, should be 
considered a distinct phenomenon within chemsex populations since, it may 
be argued, both reinforcers for engaging in the behavior and consequences are 
distinct from other forms of drug injecting. An unintended consequence of 
enforcement of drug restrictions in licensed venues and premises (arguably in 
response to pressure from both law enforcement and broader public health 
agendas) may have contributed to a transition to private parties which may 
facilitate the engagement of MSM in “SIDU” (Moncrieff, 2014).
The underground nature with which SIDU amongst MSM is associated and 
the extreme sexualized injecting it can lead to make those who engage with the 
practices a “hard to reach” population in relation to harm reduction initiatives. 
As we have indicated, some attempts have been made to engage with this 
population, however data as to success in such engagement are weak. 
Furthermore, the nature of the engagement, such as the provision of syringes 
and latex gloves for the purpose of public protection through the promotion of 
safer extreme sexual practices may be publicly controversial and may 
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discourage mainstream statutory public health bodies from providing the 
specialist service that is needed.
In this context, the initiation into “SIDU” may be a “line in the sand” (Smith 
& Tasker, 2017; Wharton, 2017) which exposes MSM to greater physical and 
mental health harms that cannot be addressed by health services because of the 
stigmatized nature of the practices within wider society (sexualized injecting 
and extreme sexual behavior). Yet such a stigmatized group could pose 
a health risk to the wider MSM population if their practices are not addressed 
through specialized public health response that does not alienate them.
Traditional services for PWID appear to be ill-suited for people engaging in 
“SIDU” (Stuart, 2016). Central to effective services, the literature scoping 
review seems to indicate, is to develop an individualized sex-positive led 
approach characterized by cultural competence which integrates with other 
sexual health-related and addiction services (Bakker & Knoops, 2018; Frankis 
& Clutterbuck, 2017; Knowles, 2019).
Limitations
We only included English language studies and as a result have excluded 
research from other pertinent regions such as Asia and South America. 
Several studies were excluded as they conflated reported injection of chemsex 
drugs with “SIDU.” The reported injection of chemsex drugs may be indicative 
of “SIDU” but such drugs may be injected in other contexts and their inclusion 
could have led to the contamination of the review with the injection by MSM 
of chemsex drugs in other contexts.
Conclusions
Future studies of MSM engaging in chemsex should report specifically on the 
engagement in “SIDU.” Care should be taken not to conflate reported injecting 
drug use with “SIDU” as “SIDU” is associated with differing practices, risks, and 
service needs. Law enforcement should be cognizant of the potential influence of 
policing licensed premises on increased prevalence of “SIDU” in private parties.
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